The Market Reports

Index

1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Overview
1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Treatment Devices
1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Type
1.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Surgical Treatment
1.2.3 Minimally Invasive Treatment
1.2.4 Laser Treatment
1.2.5 Other
1.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Application
1.3.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Comparison by Application: (2021-2027)
1.3.2 Fertility Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Estimates and Forecasts
1.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2016-2027
1.4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2016-2027
1.4.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competition by Manufacturers
2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Sites, Area Served, Product Type
2.5 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competitive Situation and Trends
2.5.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Benign Prostatic Hyperplasia (BPH) Treatment Devices Players Market Share by Revenue
2.5.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Retrospective Market Scenario by Region
3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures by Country
3.3.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
3.3.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures by Country
3.4.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
3.4.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region
3.5.2 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures by Country
3.6.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
3.6.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
3.7.2 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Analysis by Type
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2021)
4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Type (2016-2021)
4.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2016-2021)

5 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Analysis by Application
5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2021)
5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application (2016-2021)
5.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Advin Urology
6.1.1 Advin Urology Corporation Information
6.1.2 Advin Urology Description and Business Overview
6.1.3 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Advin Urology Product Portfolio
6.1.5 Advin Urology Recent Developments/Updates
6.2 Biolitec
6.2.1 Biolitec Corporation Information
6.2.2 Biolitec Description and Business Overview
6.2.3 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Biolitec Product Portfolio
6.2.5 Biolitec Recent Developments/Updates
6.3 Boston Scientific Corporation
6.3.1 Boston Scientific Corporation Corporation Information
6.3.2 Boston Scientific Corporation Description and Business Overview
6.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Boston Scientific Corporation Product Portfolio
6.3.5 Boston Scientific Corporation Recent Developments/Updates
6.4 CONMED
6.4.1 CONMED Corporation Information
6.4.2 CONMED Description and Business Overview
6.4.3 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CONMED Product Portfolio
6.4.5 CONMED Recent Developments/Updates
6.5 Convergent Laser Technologies
6.5.1 Convergent Laser Technologies Corporation Information
6.5.2 Convergent Laser Technologies Description and Business Overview
6.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Convergent Laser Technologies Product Portfolio
6.5.5 Convergent Laser Technologies Recent Developments/Updates
6.6 CoreTherm Medical, Inc. (ProstaLund)
6.6.1 CoreTherm Medical, Inc. (ProstaLund) Corporation Information
6.6.2 CoreTherm Medical, Inc. (ProstaLund) Description and Business Overview
6.6.3 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 CoreTherm Medical, Inc. (ProstaLund) Product Portfolio
6.6.5 CoreTherm Medical, Inc. (ProstaLund) Recent Developments/Updates
6.7 HistoSonics, Inc.
6.6.1 HistoSonics, Inc. Corporation Information
6.6.2 HistoSonics, Inc. Description and Business Overview
6.6.3 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 HistoSonics, Inc. Product Portfolio
6.7.5 HistoSonics, Inc. Recent Developments/Updates
6.8 JenaSurgical GmbH
6.8.1 JenaSurgical GmbH Corporation Information
6.8.2 JenaSurgical GmbH Description and Business Overview
6.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 JenaSurgical GmbH Product Portfolio
6.8.5 JenaSurgical GmbH Recent Developments/Updates
6.9 KARL STORZ
6.9.1 KARL STORZ Corporation Information
6.9.2 KARL STORZ Description and Business Overview
6.9.3 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 KARL STORZ Product Portfolio
6.9.5 KARL STORZ Recent Developments/Updates
6.10 LISA Laser Products GmbH
6.10.1 LISA Laser Products GmbH Corporation Information
6.10.2 LISA Laser Products GmbH Description and Business Overview
6.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 LISA Laser Products GmbH Product Portfolio
6.10.5 LISA Laser Products GmbH Recent Developments/Updates
6.11 Lumenis Ltd.
6.11.1 Lumenis Ltd. Corporation Information
6.11.2 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
6.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Lumenis Ltd. Product Portfolio
6.11.5 Lumenis Ltd. Recent Developments/Updates
6.12 Medifocus, Inc.
6.12.1 Medifocus, Inc. Corporation Information
6.12.2 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
6.12.3 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Medifocus, Inc. Product Portfolio
6.12.5 Medifocus, Inc. Recent Developments/Updates
6.13 Endo International
6.13.1 Endo International Corporation Information
6.13.2 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
6.13.3 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Endo International Product Portfolio
6.13.5 Endo International Recent Developments/Updates
6.14 Medtronic
6.14.1 Medtronic Corporation Information
6.14.2 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
6.14.3 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Medtronic Product Portfolio
6.14.5 Medtronic Recent Developments/Updates
6.15 Siemens
6.15.1 Siemens Corporation Information
6.15.2 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
6.15.3 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Siemens Product Portfolio
6.15.5 Siemens Recent Developments/Updates
6.16 Olympus
6.16.1 Olympus Corporation Information
6.16.2 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
6.16.3 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Olympus Product Portfolio
6.16.5 Olympus Recent Developments/Updates
6.17 Urologix
6.17.1 Urologix Corporation Information
6.17.2 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
6.17.3 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Urologix Product Portfolio
6.17.5 Urologix Recent Developments/Updates
6.18 NeoTract
6.18.1 NeoTract Corporation Information
6.18.2 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
6.18.3 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.18.4 NeoTract Product Portfolio
6.18.5 NeoTract Recent Developments/Updates
6.19 Urotech
6.19.1 Urotech Corporation Information
6.19.2 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
6.19.3 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Urotech Product Portfolio
6.19.5 Urotech Recent Developments/Updates
6.20 Baxter International
6.20.1 Baxter International Corporation Information
6.20.2 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
6.20.3 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Baxter International Product Portfolio
6.20.5 Baxter International Recent Developments/Updates

7 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Cost Analysis
7.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
7.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List
8.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers

9 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Dynamics
9.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Trends
9.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Growth Drivers
9.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Challenges
9.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Restraints

10 Global Market Forecast
10.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2022-2027)
10.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application (2022-2027)
10.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Covered in This Study
Table 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Manufacturers (2016-2021)
Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type
Table 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2016-2021) & (K Units)
Table 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2016-2021)
Table 17. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (K Units)
Table 19. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2016-2021)
Table 20. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (K Units)
Table 23. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2016-2021)
Table 39. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2021)
Table 40. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Type (2016-2021)
Table 42. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Type (2016-2021)
Table 43. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Application (2016-2021)
Table 44. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2021)
Table 45. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Application (2016-2021)
Table 47. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Application (2016-2021)
Table 48. Advin Urology Corporation Information
Table 49. Advin Urology Description and Business Overview
Table 50. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 52. Advin Urology Recent Developments/Updates
Table 53. Biolitec Corporation Information
Table 54. Biolitec Description and Business Overview
Table 55. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 57. Biolitec Recent Developments/Updates
Table 58. Boston Scientific Corporation Corporation Information
Table 59. Boston Scientific Corporation Description and Business Overview
Table 60. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 62. Boston Scientific Corporation Recent Developments/Updates
Table 63. CONMED Corporation Information
Table 64. CONMED Description and Business Overview
Table 65. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 67. CONMED Recent Developments/Updates
Table 68. Convergent Laser Technologies Corporation Information
Table 69. Convergent Laser Technologies Description and Business Overview
Table 70. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 72. Convergent Laser Technologies Recent Developments/Updates
Table 73. CoreTherm Medical, Inc. (ProstaLund) Corporation Information
Table 74. CoreTherm Medical, Inc. (ProstaLund) Description and Business Overview
Table 75. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 77. CoreTherm Medical, Inc. (ProstaLund) Recent Developments/Updates
Table 78. HistoSonics, Inc. Corporation Information
Table 79. HistoSonics, Inc. Description and Business Overview
Table 80. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 82. HistoSonics, Inc. Recent Developments/Updates
Table 83. JenaSurgical GmbH Corporation Information
Table 84. JenaSurgical GmbH Description and Business Overview
Table 85. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 87. JenaSurgical GmbH Recent Developments/Updates
Table 88. KARL STORZ Corporation Information
Table 89. KARL STORZ Description and Business Overview
Table 90. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 92. KARL STORZ Recent Developments/Updates
Table 93. LISA Laser Products GmbH Corporation Information
Table 94. LISA Laser Products GmbH Description and Business Overview
Table 95. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 97. LISA Laser Products GmbH Recent Developments/Updates
Table 98. Lumenis Ltd. Corporation Information
Table 99. Lumenis Ltd. Description and Business Overview
Table 100. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 102. Lumenis Ltd. Recent Developments/Updates
Table 103. Medifocus, Inc. Corporation Information
Table 104. Medifocus, Inc. Description and Business Overview
Table 105. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 107. Medifocus, Inc. Recent Developments/Updates
Table 108. Endo International Corporation Information
Table 109. Endo International Description and Business Overview
Table 110. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 112. Endo International Recent Developments/Updates
Table 113. Medtronic Corporation Information
Table 114. Medtronic Description and Business Overview
Table 115. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 117. Medtronic Recent Developments/Updates
Table 118. Siemens Corporation Information
Table 119. Siemens Description and Business Overview
Table 120. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 122. Siemens Recent Developments/Updates
Table 123. Olympus Corporation Information
Table 124. Olympus Description and Business Overview
Table 125. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 127. Olympus Recent Developments/Updates
Table 128. Urologix Corporation Information
Table 129. Urologix Description and Business Overview
Table 130. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 132. Urologix Recent Developments/Updates
Table 133. NeoTract Corporation Information
Table 134. NeoTract Description and Business Overview
Table 135. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 137. NeoTract Recent Developments/Updates
Table 138. Urotech Corporation Information
Table 139. Urotech Description and Business Overview
Table 140. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 142. Urotech Recent Developments/Updates
Table 143. Baxter International Corporation Information
Table 144. Baxter International Description and Business Overview
Table 145. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 147. Baxter International Recent Developments/Updates
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List
Table 151. Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers List
Table 152. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Trends
Table 153. Benign Prostatic Hyperplasia (BPH) Treatment Devices Growth Drivers
Table 154. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Restraints
Table 155. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 156. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Type (2022-2027)
Table 157. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 158. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Type (2022-2027)
Table 159. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 160. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Application (2022-2027)
Table 161. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 162. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Application (2022-2027)
Table 163. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 164. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Region (2022-2027)
Table 165. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 166. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Region (2022-2027)
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Type in 2020 & 2027
Figure 3. Surgical Treatment Product Picture
Figure 4. Minimally Invasive Treatment Product Picture
Figure 5. Laser Treatment Product Picture
Figure 6. Other Product Picture
Figure 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application in 2020 & 2027
Figure 8. Fertility Clinics
Figure 9. Hospitals
Figure 10. Others
Figure 11. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size 2016-2027 (US$ Million)
Figure 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2016-2027 (K Units)
Figure 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Manufacturers in 2020
Figure 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Benign Prostatic Hyperplasia (BPH) Treatment Devices Players: Market Share by Revenue in 2020
Figure 18. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2016-2021)
Figure 20. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region in 2020
Figure 21. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2016-2021)
Figure 22. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region in 2020
Figure 23. U.S. Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2016-2021)
Figure 48. Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application (2016-2021)
Figure 49. Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application in 2020
Figure 50. Revenue Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application (2016-2021)
Figure 51. Revenue Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application in 2020
Figure 52. Manufacturing Cost Structure of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 53. Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 54. Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed